Study: NCT00169442

Adverse event: Pneumonia
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 85 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 8 affected / 85 at risk

Adverse event: Pain (post-booster)
Serious: no
Organ System: General disorders
Frequency: 56 affected / 82 at risk

Adverse event: Redness (post-booster)
Serious: no
Organ System: General disorders
Frequency: 46 affected / 82 at risk

Adverse event: Swelling (post-booster)
Serious: no
Organ System: General disorders
Frequency: 44 affected / 82 at risk

Adverse event: Drowsiness (post-booster)
Serious: no
Organ System: General disorders
Frequency: 34 affected / 82 at risk

Adverse event: Fever (Axillary) (post-booster)
Serious: no
Organ System: General disorders
Frequency: 59 affected / 82 at risk

Adverse event: Iritability (post-booster)
Serious: no
Organ System: General disorders
Frequency: 54 affected / 82 at risk

Adverse event: Loss of appetite (post-booster)
Serious: no
Organ System: General disorders
Frequency: 25 affected / 82 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 8 affected / 410 at risk

Adverse event: Pain (post-booster)
Serious: no
Organ System: General disorders
Frequency: 303 affected / 409 at risk

Adverse event: Redness (post-booster)
Serious: no
Organ System: General disorders
Frequency: 255 affected / 409 at risk

Adverse event: Swelling (post-booster)
Serious: no
Organ System: General disorders
Frequency: 250 affected / 409 at risk

Adverse event: Drowsiness (post-booster)
Serious: no
Organ System: General disorders
Frequency: 174 affected / 409 at risk

Adverse event: Fever (Axillary) (post-booster)
Serious: no
Organ System: General disorders
Frequency: 270 affected / 409 at risk

Adverse event: Iritability (post-booster)
Serious: no
Organ System: General disorders
Frequency: 267 affected / 409 at risk

Adverse event: Loss of appetite (post-booster)
Serious: no
Organ System: General disorders
Frequency: 129 affected / 409 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Frequency: 8 affected / 250 at risk

Adverse event: Pain (post-booster)
Serious: no
Organ System: General disorders
Frequency: 181 affected / 250 at risk

Adverse event: Redness (post-booster)
Serious: no
Organ System: General disorders
Frequency: 152 affected / 250 at risk

Adverse event: Swelling (post-booster)
Serious: no
Organ System: General disorders
Frequency: 140 affected / 250 at risk

Adverse event: Drowsiness (post-booster)
Serious: no
Organ System: General disorders
Frequency: 105 affected / 250 at risk

Adverse event: Fever (Axillary) (post-booster)
Serious: no
Organ System: General disorders
Frequency: 168 affected / 250 at risk

Adverse event: Iritability (post-booster)
Serious: no
Organ System: General disorders
Frequency: 162 affected / 250 at risk

Adverse event: Loss of appetite (post-booster)
Serious: no
Organ System: General disorders
Frequency: 79 affected / 250 at risk

Adverse event: Pain (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 13 affected / 42 at risk

Adverse event: Redness (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 11 affected / 42 at risk

Adverse event: Swelling (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 42 at risk

Adverse event: Drowsiness (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 6 affected / 42 at risk

Adverse event: Fever (Axillary) (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 42 at risk

Adverse event: Irritability (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 11 affected / 42 at risk

Adverse event: Loss of appetite (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 42 at risk

Adverse event: Pain (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 12 affected / 43 at risk

Adverse event: Redness (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 15 affected / 43 at risk

Adverse event: Swelling (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 11 affected / 43 at risk

Adverse event: Drowsiness (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 10 affected / 43 at risk

Adverse event: Fever (Axillary) (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 43 at risk

Adverse event: Irritability (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 8 affected / 43 at risk

Adverse event: Loss of appetite (post-PRP challenge)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 43 at risk